The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

The FDA is allowing pharmacies to dispense compounded versions of semaglutide and tirzepatide ... of the weight loss drugs — large amounts of people qualify for them and their high cost ...

“The term osteoporosis screening refers to use of bone density, x-ray studies or other tools to identify persons at an increased risk of fractures or bone breaks,” Dr. Thomas Weber, an endocrinologist ...

Eli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.